Acute myeloid leukemia, version 2.2013 featured updates to the NCCN guidelines Journal Article


Authors: O'Donnell, M. R.; Tallman, M. S.; Abboud, C. N.; Altman, J. K.; Appelbaum, F. R.; Arber, D. A.; Attar, E.; Borate, U.; Coutre, S. E.; Damon, L. E.; Lancet, J.; Maness, L. J.; Marcucci, G.; Martin, M. G.; Millenson, M. M.; Moore, J. O.; Ravandi, F.; Shami, P. J.; Smith, B. D.; Stone, R. M.; Strickland, S. A.; Wang, E. S.; Gregory, K. M.; Naganuma, M.
Article Title: Acute myeloid leukemia, version 2.2013 featured updates to the NCCN guidelines
Abstract: These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Acute Myeloid Leukemia and discuss the clinical evidence that support the recommendations. The updates described in this article focus on the acute promyelocytic leukemia (APL) section, featuring recommendations for additional induction/consolidation regimens in patients with low- or intermediate-risk APL, and providing guidance on maintenance strategies for APL. © JNCCN-Journal of the National Comprehensive Cancer Network.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 11
Issue: 9
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2013-09-01
Start Page: 1047
End Page: 1055
Language: English
PROVIDER: scopus
PUBMED: 24029121
PMCID: PMC4161234
DOI/URL:
Notes: --- - "Export Date: 1 November 2013" - "Source: Scopus"
Citation Impact
MSK Authors
  1. Martin Stuart Tallman
    649 Tallman